Ontex reported a revenue of €445 million in Q3 2025, down 3.8% like-for-like from the previous year. Despite softer market demand, volume growth increased by 3.7% due to contract gains. Adjusted EBITDA margin was 11.4%, with a full-year outlook maintained by CEO Gustavo Calvo Paz. Cost optimization and volume gains remain key drivers.

In a business review, Ontex’s revenue decline was attributed to lower volumes, particularly in baby care, offset by new contracts. Adult care volumes increased, while feminine care and adult care saw slight growth. Stable sales prices and cost optimization led to a 3.0pp increase in adjusted EBITDA margin compared to Q2, totaling €51 million.

The cost transformation program delivered €16 million in net savings, offsetting higher raw material prices. Revenue recovery and cost optimization led to an improvement in adjusted EBITDA by €15 million from the previous quarter. Operating profit was €29 million, with net financial debt at €543 million. Ontex maintains its full-year outlook with revenue expected to decrease slightly, adjusted EBITDA in the range of €200-210 million, and leverage around 2.5x by year-end. In the third quarter of 2025, Ontex experienced fluctuations in Forex but had no significant impact. The adjusted EBITDA margin was 11.4%, a decrease of 0.6 percentage points from 2024, but a 3.0 percentage point increase from the second quarter of 2025. Operating profit from continuing operations was €29 million, compared to €8 million in 2024.

Discontinued operations, including Turkish business activities, generated €23 million in revenue with adjusted EBITDA of €2 million. Net financial debt for the Total Group decreased by €9 million to €543 million, resulting from positive free cash flow generation. The leverage ratio remained at 2.7x due to lower adjusted EBITDA over the last twelve months.

Ontex Group NV’s financial information for the nine months ending September 30, 2025, was authorized for issue on October 29, 2025. Ontex is a leading international developer and producer of baby care, feminine care, and adult care products, with plants and offices in 12 countries and distribution in around 100 countries. The company is headquartered in Aalst, Belgium, and listed on Euronext Brussels.

Read more at GlobeNewswire.: Ontex reports sequential improvement across key financial